Diskussionsleiter: F. Limbourg (Hannover), M. Potente (Frankfurt am Main)
| (P1721) | Normal endothelial but altered arterial development in MAPK-activated protein kinase 2 deficient mice. |
| O. Jabs, P. R. Kapopara, M. Gaestel, D. Fraccarollo, J. Bauersachs, U. Bavendiek, L. C. Napp (Hannover) | |
| (P1722) | Endo-PDI is required for endothelial angiogenic function |
| A. Babelova, L. de Lucca Camargo, L. Rossetti Lopes, R. P. Brandes (Frankfurt am Main; São Paulo, BR) | |
| (P1723) | Der duale PPAR-α/γ-Agonist Aleglitazar steigert die Anzahl und Funktion endothelialer Progenitorzellen, verbessert Neoangiogenese und vaskuläre Funktion und hemmt die Atherogenese in Mäusen |
| C. Werner, C. Gensch, V. Pavlickova, J. Pöss, M. Wright, M. Böhm, U. Laufs (Homburg/Saar; Bern, CH) | |
| (P1724) | Nephronectin regulates axial vein morphogenesis in zebrafish |
| C. Patra, F. Ricciardi, I. Bethani, F. Cop, I. Nikolic, M. Schmidt, A. Acker Palmer, B. Jungblut, F. Engel (Bad Nauheim, Frankfurt am Main, Mainz) | |
| (P1725) | Müller cells regulate Notch signaling and retinal angiogenesis via the soluble epoxide hydrolase-dependent generation of 19,20-dihydroxydocosapentaenoic acid |
| J. Hu, R. Popp, T. Frömel, M. Ehling, K. Awwad, R. H. Adams, I. Fleming (Frankfurt am Main, Münster) | |
| (P1726) | AMPK independent anti-angiogenic effects of AMPK inhibitors compound C and arabinofuranosyl adenine |
| M. Aslam, L. Li, C. W. Hamm, D. Gündüz, R. Schulz, S. Rohrbach (Gießen, Bad Nauheim) | |
| (P1727) | Reconciling the role of HIF‑3α: Inhibition of HIF‑2 activity in endothelial cells |
| F. Rieß, D. Kracun, S. Bonello, M. Weitnauer, T. Kietzmann, A. Görlach (München; Oulu, FI) | |
| (P1728) | The transcription factor NPAS4 is a strong inducer of tip cell formation and sprouting angiogenesis |
| A. Charlet, M. Schmidt, S. Heck, J. Heinke, B. Engert, D. Epting, A. Kramer-Zucker, C. Patterson, C. Bode, M. Moser (Freiburg im Breisgau; Chapel Hill, US) | |
| (P1729) | Thymosin beta 4 induced neovascularization: Role of MRTF activation |
| T. Trenkwalder, R. Hinkel, Q. Di, S. Sultana, C. Lebherz, E. Hannappel, G. Posern, I. Bock-Marquette, S. Massberg, E. Deindl, C. Kupatt (München, Erlangen, Halle/Saale; Dallas, US) | |
| (P1730) | Toll-like Receptor 2/6-Dependent Stimulation of Mesenchymal Stem Cells Promotes Angiogenesis in vitro and in vivo |
| K. Grote, M. Petri, S. Spalthoff, P. Jehn, H. Kokemüller, M. Jagodzinski (Hannover) | |
| (P1731) | Paracrine inhibition of angiogenesis by platelets via interaction with macrophages |
| J. Patzelt, H. Nording, R. Schleicher, T. Persicke, S. Gekeler, F. Emschermann, M. Gawaz, H.-F. Langer (Tübingen) | |
| (P1732) | Die Rolle des Anaphylatoxinrezeptors C5aR für die Modulation von Angiogenese durch Thrombozyten |
| H. Nording, J. Patzelt, F. Emschermann, M. Gawaz, H.-F. Langer (Tübingen) | |
| (P1733) | Importance of tumor suppressor gene p53-mediated endothelial cell apoptosis for cardiac angiogenesis and hypertrophy |
| R. Gogiraju, J. Steinbrecher, S. Lehnart, M. Kessel, M. Dobbelstein, K. Schäfer (Göttingen) |